Semalytix raised EUR 4.3m in Series A led by btov

News, Portfolio

31st August 2020

Semalytix, the Bielefeld-based startup that offers pharmaceutical companies an AI-powered data tool to better understand real-world patient experiences, has raised €4.3 million in Series A funding which is led by btov Partners, with participation from existing investor Fly Ventures.

Semalytix will use the injection of cash to expand its business development with pharma companies and the wider healthcare market.

Welcome to the portfolio!

Read more over at TechCrunch here.

Press enter or esc to cancel